Correlation Between Aquestive Therapeutics and Sunshine Biopharma

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Aquestive Therapeutics and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Sunshine Biopharma.

Diversification Opportunities for Aquestive Therapeutics and Sunshine Biopharma

-0.49

Correlation Coefficient

Aquestive Therapeutics  Sunshine Biopharma

Very good diversification

The 3 months correlation between Aquestive and Sunshine is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Sunshine Biopharma

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 25.18 times less return on investment than Sunshine Biopharma. But when comparing it to its historical volatility, Aquestive Therapeutics is 14.3 times less risky than Sunshine Biopharma. It trades about 0.05 of its potential returns per unit of risk. Sunshine Biopharma Warrant is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  18.00  in Sunshine Biopharma Warrant on October 7, 2024 and sell it today you would earn a total of  1.00  from holding Sunshine Biopharma Warrant or generate 5.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	83.47%
Values	Daily Returns

Aquestive Therapeutics  vs.  Sunshine Biopharma Warrant

Aquestive Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Sunshine Biopharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aquestive Therapeutics and Sunshine Biopharma

The main advantage of trading using opposite Aquestive Therapeutics and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.

The idea behind Aquestive Therapeutics and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.